Risultati della ricerca - Werd Al‐Najim

  • Mostra 1 - 5 risultati su 5
Raffina i risultati
  1. 1
    Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes

    Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes di F Contreras, Werd Al‐Najim, Carel W. le Roux

    Pubblicazione 2024
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Food Intake and Eating Behavior After Bariatric Surgery

    Food Intake and Eating Behavior After Bariatric Surgery di Werd Al‐Najim, Neil G. Docherty, Carel W. le Roux

    Pubblicazione 2018
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

    The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers di Tricia Tan, Preeshila Behary, George Tharakan, James Minnion, Werd Al‐Najim, Nicolai J. Wewer Albrechtsen, Jens J. Holst, Stephen R. Bloom

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial

    Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomi... di Dimitris Papamargaritis, Werd Al‐Najim, Jonathan Lim, James P. Crane, Danielle H. Bodicoat, Shaun Barber, Michael E. J. Lean, Barbara McGowan, Donal O’Shea, David R. Webb, John Wilding, Carel W. le Roux, Melanie J. Davies

    Pubblicazione 2024
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

    Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial di Alexander D. Miras, Belén Pérez‐Pevida, Madhawi Aldhwayan, Anna Kamocka, Emma Rose McGlone, Werd Al‐Najim, Harvinder Chahal, Rachel L. Batterham, Barbara McGowan, Omar Khan, Veronica Greener, Ahmed R. Ahmed, Aviva Petrie, Samantha Scholtz, Stephen R. Bloom, Tricia Tan

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: